Literature DB >> 26261629

Detecting of gastric cancer by Bcl-2 and Ki67.

Yongli Zhou1, Yandong Li2, Jianyun Zheng2, Kaige Liu1, Hongmei Zhang3.   

Abstract

Gastric cancer is one of the most common malignant tumors and the second leading cause of cancer-related deaths in China. Although there is some progress in diagnose and treatment, the incidence of gastric cancer still keeps up increasing. In this study 40 patients with gastric cancer who underwent surgical operation is detected by immunohistochemistry. The positive rates of Bcl-2 and Ki67 protein expression in gastric cancer tissues were significantly higher than normal gastric mucous tissues. Correlation analysis showed that the expression of Bcl-2 is not correlated with that of Ki67. Positive expression of Bcl-2 or Ki67 did not correlate with age, gender, differentiation, stage and lymph node metastasis. These suggested that combination of Bcl-2 and Ki67 to detect gastric cancer is more effective.

Entities:  

Keywords:  Bcl-2; Ki67; gastric cancer; immunohistochemistry

Mesh:

Substances:

Year:  2015        PMID: 26261629      PMCID: PMC4525963     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

Review 1.  Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion.

Authors:  B Antonsson
Journal:  Cell Tissue Res       Date:  2001-10-30       Impact factor: 5.249

2.  Prognostic significance of p53 and Ki67 proteins expression in Greek gastric cancer patients.

Authors:  N E Tzanakis; G Peros; P Karakitsos; G A Giannopoulos; S P Efstathiou; G Rallis; Chr Tsigris; A Kostakis; N I Nikiteas
Journal:  Acta Chir Belg       Date:  2009-10       Impact factor: 1.090

3.  Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study.

Authors:  George K Anagnostopoulos; Dimitrios Stefanou; Evdokia Arkoumani; George Sakorafas; George Pavlakis; Dimitrios Arvanitidis; Epameinondas Tsianos; Niki J Agnantis
Journal:  J Gastroenterol Hepatol       Date:  2005-11       Impact factor: 4.029

4.  Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.

Authors:  Jose A Karam; Yair Lotan; Pierre I Karakiewicz; Raheela Ashfaq; Arthur I Sagalowsky; Claus G Roehrborn; Shahrokh F Shariat
Journal:  Lancet Oncol       Date:  2007-02       Impact factor: 41.316

5.  The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.

Authors:  M S Al-Moundhri; V Nirmala; I Al-Hadabi; K Al-Mawaly; I Burney; M Al-Nabhani; V Thomas; S S Ganguly; C Grant
Journal:  J Surg Oncol       Date:  2005-09-15       Impact factor: 3.454

6.  Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.

Authors:  Yao Zheng; Lin Wang; Jian-Ping Zhang; Jing-Yan Yang; Zhu-Mei Zhao; Xiao-Ying Zhang
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

7.  Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.

Authors:  Koji Morimoto; Seung Jin Kim; Tomonori Tanei; Kenzo Shimazu; Yoshio Tanji; Tetsuya Taguchi; Yasuhiro Tamaki; Nobuyuki Terada; Shinzaburo Noguchi
Journal:  Cancer Sci       Date:  2009-03-09       Impact factor: 6.716

8.  The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.

Authors:  Athanassios C Tsamandas; Dimitrios Kardamakis; Pantelis Tsiamalos; Anna Liava; Vassiliki Tzelepi; Vassilios Vassiliou; Theodore Petsas; Konstantinos Vagenas; Vassiliki Zolota; Chrisoula D Scopa
Journal:  Anticancer Res       Date:  2009-02       Impact factor: 2.480

9.  Immunohistochemical expression of TGF beta (TGF-β), TGF beta receptor 1 (TGFBR1), and Ki67 in intestinal variant of gastric adenocarcinomas.

Authors:  Anca Oana Docea; P Mitruţ; Diana Grigore; D Pirici; Daniela Cornelia Călina; Eliza Gofiţă
Journal:  Rom J Morphol Embryol       Date:  2012       Impact factor: 1.033

10.  Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma.

Authors:  Li Chen; Xinyu Li; Guei-Lan Wang; Yu Wang; York-Yuan Zhu; Jianwei Zhu
Journal:  Tumori       Date:  2008 Jul-Aug
View more
  11 in total

1.  Anti-Cancer Activity of Gedunin by Induction of Apoptosis in Human Gastric Cancer AGS Cells.

Authors:  Heying Zhou; Fengxia Li; Yanli Li
Journal:  Appl Biochem Biotechnol       Date:  2022-06-27       Impact factor: 3.094

2.  Nesfatin-1 is a potential diagnostic biomarker for gastric cancer.

Authors:  Xiao-Qing Wang; Yan Zheng; Pei-Fei Fang; Xian-Bing Song
Journal:  Oncol Lett       Date:  2019-12-10       Impact factor: 2.967

3.  Serum metabolomic profiling of human gastric cancer and its relationship with the prognosis.

Authors:  Daguang Wang; Wei Li; Qi Zou; Lei Yin; Yechao Du; Jingkai Gu; Jian Suo
Journal:  Oncotarget       Date:  2017-09-28

4.  Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer: a systematic review and meta-analysis.

Authors:  Gang Liu; Disheng Xiong; Junjie Zeng; Borong Chen; Zhengjie Huang
Journal:  Onco Targets Ther       Date:  2017-09-01       Impact factor: 4.147

5.  UPF1 inhibits the hepatocellular carcinoma progression by targeting long non-coding RNA UCA1.

Authors:  Yongli Zhou; Yandong Li; Na Wang; Xiuying Li; Jianyun Zheng; Liqiao Ge
Journal:  Sci Rep       Date:  2019-04-30       Impact factor: 4.379

6.  Ki-67/MKI67 as a Predictive Biomarker for Clinical Outcome in Gastric Cancer Patients: an Updated Meta-analysis and Systematic Review involving 53 Studies and 7078 Patients.

Authors:  Dan-Dan Xiong; Chu-Mei Zeng; Ling Jiang; Dian-Zhong Luo; Gang Chen
Journal:  J Cancer       Date:  2019-08-29       Impact factor: 4.207

7.  Estrogen Receptor Beta Inhibits The Proliferation, Migration, And Angiogenesis Of Gastric Cancer Cells Through Inhibiting Nuclear Factor-Kappa B Signaling.

Authors:  Yiping Zhang; Yahua Wu; Xufeng Zhou; Benyi Yi; Lili Wang
Journal:  Onco Targets Ther       Date:  2019-11-05       Impact factor: 4.147

8.  Expression of the cytoskeleton regulatory protein Mena in human gastric carcinoma and its prognostic significance.

Authors:  Lihua Xu; Huo Tan; Ruiming Liu; Qungai Huang; Nana Zhang; Xi Li; Jiani Wang
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

9.  Expression and significance of Her2 and Ki-67 in gastric adenocarcinoma without distant metastasis: a cohort study.

Authors:  Zhijian Wei; Lei Huang; Xinyue Zhang; Aman Xu
Journal:  BMC Gastroenterol       Date:  2020-10-15       Impact factor: 3.067

10.  Gastric Cancer Heterogeneity and Clinical Outcomes.

Authors:  Rachel E Sexton; Mohammed Najeeb Al Hallak; Md Hafiz Uddin; Maria Diab; Asfar S Azmi
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.